BRG Extends International Healthcare, Pharmaceuticals, and Medical Device Practice

Leading expert services and data analytics firm Berkeley Research Group, LLC (BRG), today announced the appointment of several new experts, further bolstering its expert advisory services and range of expertise across the healthcare, pharmaceutical, and medical device sectors.

“Rapid growth and recent healthcare reform legislation from earlier this year are changing the landscape of the industry, as well as presenting new regulatory challenges for healthcare companies,” stated BRG Chairman and Principal Executive Officer David J. Teece. “We are pleased to have several prominent experts in this field to lead our Health Analytics practice, and anticipate that each will play an important role in advising our clients on these pivotal issues.”

BRG’s Health Analytics practice has extensive healthcare, pharmaceutical and life sciences expertise and provides investigation, litigation, dispute resolution, regulatory compliance, policy, and advisory services to clients and their outside counsel. Seven distinguished experts will lead the BRG Health Analytics practice as directors:

Kevin O’Brien leads BRG’s Chicago office and is joined by Cher Fieri.

Tri MacDonald leads BRG’s Washington, DC, office and is joined by Jerry Lewandowski and Dr. Henry Miller.

Mark Abernathy leads BRG’s Tampa, Florida, office and is joined by Julie Nielsen.